The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Phase II clinical trial of bevacizumab plus ixabepilone in renal cell carcinoma.
Mauricio Emmanuel Burotto Pichun
No relevant relationships to disclose
Nicolas Acquavella
No relevant relationships to disclose
Maureen Edgerly
No relevant relationships to disclose
Susan Elaine Bates
No relevant relationships to disclose
Sanjeeve Balasubramaniam
No relevant relationships to disclose
Antonio Tito Fojo
No relevant relationships to disclose